Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double‐blind, placebo‐controlled, crossover study-Reference-Cited by-同舟云学术

Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double‐blind, placebo‐controlled, crossover study

Published:2020-03-18 Issue:4 Volume:29 Page:
ISSN:0962-1105
Container-title:Journal of Sleep Research
language:en
Short-container-title:J Sleep Res

Author:

Cheng Jocelyn Y.¹^ORCID,Filippov Gleb¹,Moline Margaret¹,Zammit Gary K.²,Bsharat Mohammad¹,Hall Nancy¹

Affiliation:

1. Eisai Inc. Woodcliff Lake New Jersey USA

2. Clinilabs Drug Development Drug Corporation New York New York USA

Funder

Eisai Inc.

Publisher

Wiley

Subject

Behavioral Neuroscience,Cognitive Neuroscience,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jsr.13021

Reference24 articles.

1. Obstructive sleep apnea during rapid eye movement sleep

2. Triazolam in patients with obstructive sleep apnea.

3. The Severity of Sleep Disordered Breathing Induces Different Decrease in the Oxygen Saturation During Rapid Eye Movement and Non-Rapid Eye Movement Sleep

4. Zolpidem-polysomnographic study of the effect of a new hypnotic drug in sleep apnea syndrome

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Respiratory safety of lemborexant in adult and elderly subjects with moderate‐to‐severe chronic obstructive pulmonary disease;Journal of Sleep Research;2024-09-12

2. The effect of the initial administration of suvorexant on severe sleep apnea syndrome;Sleep and Biological Rhythms;2024-09-12

3. JCS 2023 Guideline on Diagnosis and Treatment of Sleep Disordered Breathing in Cardiovascular Disease;Circulation Journal;2024-08-26

4. Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities;Neuropharmacology;2024-03

5. Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease;Annual Review of Pharmacology and Toxicology;2024-01-23